BiochemistrybioRxivPreprint
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
W. Rut, Z. Lv, M. Zmudzinski…·S. K. Olsen
This study profiles SARS-CoV-2-PLpro activity and determines inhibitor structures to guide anti-COVID-19 drug design.
DOI 10.1101/2020.04.29.068890